Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Treasury Shares: 2019-2024

Historic Treasury Shares for Organogenesis Holdings (ORGO) over the last 6 years, with Dec 2024 value amounting to $4.5 million.

  • Organogenesis Holdings' Treasury Shares rose 11.08% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 11.08%. This contributed to the annual value of $4.5 million for FY2024, which is 16.19% up from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Treasury Shares is $4.5 million, which was up 16.19% from $3.9 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Treasury Shares peaked at $4.5 million during FY2024, and registered a low of $764,871 during FY2021.
  • Its 3-year average for Treasury Shares is $3.3 million, with a median of $3.9 million in 2023.
  • In the last 5 years, Organogenesis Holdings' Treasury Shares decreased by 2.93% in 2021 and then skyrocketed by 182.18% in 2023.
  • Over the past 5 years, Organogenesis Holdings' Treasury Shares (Yearly) stood at $787,923 in 2020, then dropped by 2.93% to $764,871 in 2021, then soared by 80.62% to $1.4 million in 2022, then skyrocketed by 182.18% to $3.9 million in 2023, then rose by 16.19% to $4.5 million in 2024.